Results 161 to 170 of about 7,461 (205)

Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood. [PDF]

Toxicol Rep
Monfared A, Murrell DE, Shah DS, Hoang M, Brown SD, Harirforoosh S.   +5 more
europepmc   +1 more source

Mixed-Methods Study With a Systematic Review of Personalized Drug Therapy Approaches and Survey Analysis of Pharmacogenomics in Internal Medicine. [PDF]

Cureus
Elachola MS, Sasikumarame AP, Lashari UG, Nazeer H, Koduvayalil RH, Fathima H, Ponnumundasseri SK, Ririe AK.   +7 more
europepmc   +1 more source

Retrospective modeling study of ChatGPT (GPT 4) warfarin dose adjustment in patients with INRs outside the therapeutic range. [PDF]

Digit Health
Tezcan H, Tunçez A, Özen Y, Yalçın MU, Gürses KM.   +4 more
europepmc   +1 more source

A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications. [PDF]

NPJ Genom Med
Shorbaji A, Pushparaj PN, Al-Ghafari AB, Mira LS, Basabrain MA, Naseer MI, Ahmed F, Abu-Elmagd M, Rasool M, Bakhashab S.   +9 more
europepmc   +1 more source

Anticoagulation Therapies and microRNAs in Heart Failure. [PDF]

Biomolecules
Spartano L, Lombardi M, Foglieni C.
europepmc   +1 more source

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children [PDF]

core   +1 more source

Comment on "Exploring the complex relationship between Vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients". [PDF]

Int J Surg
Chen J, Li J, Chen G.
europepmc   +1 more source

Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry. [PDF]

Clin Pharmacol Ther
Siu WS, Maruf AA, Shaheen SM, McCloud R, Heintz M, McAusland L, Arnold PD, Bousman CA.   +7 more
europepmc   +1 more source

Molecular Aspects of Rare Coagulation Factor Deficiencies. [PDF]

Cureus
Tourbih H, Harrach A, Bencharef H, Dehbi H, Oukkache B.   +4 more
europepmc   +1 more source